Beta Bionics (BBNX) Share-based Compensation (2024 - 2026)
Beta Bionics' Share-based Compensation history spans 3 years, with the latest figure at $5.4 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 92.8% to $5.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $19.0 million, a 142.45% increase, with the full-year FY2025 number at $16.4 million, up 156.64% from a year prior.
- Share-based Compensation hit $5.4 million in Q1 2026 for Beta Bionics, up from $4.3 million in the prior quarter.
- Over the last five years, Share-based Compensation for BBNX hit a ceiling of $5.4 million in Q1 2026 and a floor of $1.4 million in Q1 2024.
- Historically, Share-based Compensation has averaged $3.1 million across 3 years, with a median of $2.8 million in 2025.
- Biggest five-year swings in Share-based Compensation: soared 220.15% in 2025 and later soared 92.8% in 2026.
- Tracing BBNX's Share-based Compensation over 3 years: stood at $1.6 million in 2024, then soared by 177.26% to $4.3 million in 2025, then grew by 25.63% to $5.4 million in 2026.
- Business Quant data shows Share-based Compensation for BBNX at $5.4 million in Q1 2026, $4.3 million in Q4 2025, and $4.5 million in Q3 2025.